New approach to diagnosis, immunophenotypic verification and prognostic prediction for renal angiomyolipoma
DOI: https://dx.doi.org/10.18565/urology.2018.1.35-41
G.A. Demyashkin, I.N. Zaborskii
1 Research Clinical Center of JSC RZD, Department of Pathology with a Cytology Laboratory, Moscow, Russia; 2 I.M. Sechenov First Moscow State Medical University (Sechenov University), A.I. Strukov Department of Pathology, Moscow, Russia; 3 A.F. Tsyb Medical Radiological Research Center - branch of the NMRRC, Obninsk, Russia, Obninsk, Russia
Renal angiomyolipoma (AML) is a rare benign neoplasm of mesenchymal origin. AML incidence varies from 0.3 to 5%, while women suffer four times more often than men. In most cases, renal AML measures less than 4 cm, is asymptomatic and detected accidentally with computed tomography or ultrasound. A histological variant of AML need to be verified to choose management strategy and reduce the risk of complications. Histological and immunohistochemical assessment of biopsy and surgical specimens has an essential diagnostic value in determining the type and subtypes of renal neoplasms and the risk of malignancy. The study aimed to investigate pathomorphological and prognostic features (immunohistochemical characteristics) of renal AML.
Materials and methods. Patients (n=42) with CT-detected renal neoplasms underwent partial nephrectomy. The majority (n=34) of patients was admitted to the hospital urgently, often without symptoms (n=23). The surgical specimens studied were examined using light microscopy and immunohistochemistry analysis with primary mouse monoclonal antibodies to HMB-45, Melan-A, α-SMA, S-100 and SC (Novocastra, UK).
Results. All specimens showed morphological characteristics typical of AML and a positive response to antibodies against HMB-45 (ve +/3; 99.6±0.3%), Melan-A (ve + / 2, 89.6±4.3%) and SMA (ve + 2; 70.1±2.9%) and exhibited no staining with antibodies against S-100 and SK. Conclusion. Morphological study of renal AML shows that the tumor is benign, therefore partial nephrectomy, in our opinion, should be considered as an alternative to radical nephrectomy, including for sporadic giant renal AML.
Keywords: renal angiomyolipoma, diagnosis of renal angiomyolipoma, HMB-45, Melan-A, α-SMA
About the Autors
Corresponding author: G. A. Demyashkin – Histologist-Embryologist, Pathologist at the Research Clinical Center of JSC RZD; Senior Lecturer at the A.I. Strukov Department of Pathology, I.M. Sechenov First Moscow State Medical University (Sechenov University); Member of European Association of Urology, Section of Andrological Urology (ESAU), Moscow, Russia;
e-mail: doc.dga76@gmail.com